|
ABOUT COMPANY
Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. The company is headquartered in Cranbury, New Jersey.
|
EARNINGS
Gross Profit (TTM): -38958010
Market Capitalization: 311723000
Operating Margin (TTM): 0
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0.119
Revenue (TTM): 5853500
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 6.58
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -0.35
Dividend Date: 2019-03-18
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -29723352
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|